EHA 2024 | Looking forward to EHA 2024: key clinical trials to look out for in the myeloma space
Rakesh Popat
• 24 May 2024
Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD, University College London Hospitals, London, UK, speaks about key clinical trials in myeloma that will be discussed at the upcoming Congress of the European Hematology Association (EHA). He highlights the IMROZ trial (NCT03319667), the DREAMM-8 trial (NCT04484623), and trials investigating novel CAR-Ts. This interview took place at The 10th World Congress on Controversies in Multiple Myeloma (COMy) in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
